John Sperzel is Chairman, Chief Executive Officer, and member of the Board of Directors at T2 Biosystems (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens. He has spent more than three decades advancing diagnostic technologies, having served as President, Chief Executive Officer and member of the Board of Directors for a number of public and private diagnostic companies. John earned a Bachelor of Science in Business/Management from Plymouth State University and serves on the Board of Directors for Ontera, Inc. After surviving an acute, life-threatening illness that resulted in a heart transplant, and a multidrug-resistant bacterial infection that led to sepsis, John wrote a best-selling book and continues to pursue his passion of advancing life-saving technologies.